Search

Your search keyword '"Li, Christopher I."' showing total 989 results
Start Over Author "Li, Christopher I."

Refine your results

more »

more »

more »

more »

more »
989 results on '"Li, Christopher I."'

2. International survey on invasive lobular breast cancer identifies priority research questions

Author

Oesterreich, Steffi, Pate, Leigh, Lee, Adrian V, Chen, Fangyuan, Jankowitz, Rachel C, Mukhtar, Rita, Metzger, Otto, Sikora, Matthew J, Li, Christopher I, Sotiriou, Christos, Shah, Osama S, Koorman, Thijs, Ulaner, Gary, Reis-Filho, Jorge S, Davidson, Nancy M, Van Baelen, Karen, Hutcheson, Laurie, Freeney, Siobhan, Migyanka, Flora, Turner, Claire, Derksen, Patrick, Bear, Todd, and Desmedt, Christine

Subjects
Health Services and Systems, Biomedical and Clinical Sciences, Health Sciences, Oncology and Carcinogenesis, Health Disparities, Cancer, Women's Health, Clinical Research, Breast Cancer, Clinical Trials and Supportive Activities, Clinical sciences, Oncology and carcinogenesis, Epidemiology
Abstract

There is growing awareness of the unique etiology, biology, and clinical presentation of invasive lobular breast cancer (ILC), but additional research is needed to ensure translation of findings into management and treatment guidelines. We conducted a survey with input from breast cancer physicians, laboratory-based researchers, and patients to analyze the current understanding of ILC, and identify consensus research questions. 1774 participants from 66 countries respondents self-identified as clinicians (N = 413), researchers (N = 376), and breast cancer patients and advocates (N = 1120), with some belonging to more than one category. The majority of physicians reported being very/extremely (41%) to moderately (42%) confident in describing the differences between ILC and invasive breast cancer of no special type (NST). Knowledge of histology was seen as important (73%) and as affecting treatment decisions (51%), and most agreed that refining treatment guidelines would be valuable (76%). 85% of clinicians have never powered a clinical trial to allow subset analysis for histological subtypes, but the majority would consider it, and would participate in an ILC clinical trials consortium. The majority of laboratory researchers, reported being and very/extremely (48%) to moderately (29%) confident in describing differences between ILC and NST. They reported that ILCs are inadequately presented in large genomic data sets, and that ILC models are insufficient. The majority have adequate access to tissue or blood from patients with ILC. The majority of patients and advocates (52%) thought that their health care providers did not sufficiently explain the unique features of ILC. They identified improvement of ILC screening/early detection, and identification of better imaging tools as top research priorities. In contrast, both researchers and clinicians identified understanding of endocrine resistance and identifying novel drugs that can be tested in clinical trials as top research priority. In summary, we have gathered information from an international community of physicians, researchers, and patients/advocates that we expect will lay the foundation for a community-informed collaborative research agenda, with the goal of improving management and personalizing treatment for patients with ILC.

Published
2024

3. Risk factors and health behaviors associated with loneliness among cancer survivors during the COVID-19 pandemic

Author

Aßmann, Elena S., Ose, Jennifer, Hathaway, Cassandra A., Oswald, Laura B., Hardikar, Sheetal, Himbert, Caroline, Chellam, Vimalkumar, Lin, Tengda, Daniels, Bailee, Kirchhoff, Anne C., Gigic, Biljana, Grossman, Douglas, Tward, Jonathan, Varghese, Jr., Thomas K., Shibata, David, Figueiredo, Jane C., Toriola, Adetunji T., Beck, Anna, Scaife, Courtney, Barnes, Christopher A., Matsen, Cindy, Ma, Debra S., Colman, Howard, Hunt, Jason P., Jones, Kevin B., Lee, Catherine J., Larson, Mikaela, Onega, Tracy, Akerley, Wallace L., Li, Christopher I., Grady, William M., Schneider, Martin, Dinkel, Andreas, Islam, Jessica Y., Gonzalez, Brian D., Otto, Amy K., Penedo, Frank J., Siegel, Erin M., Tworoger, Shelley S., Ulrich, Cornelia M., and Peoples, Anita R.

Published
2024
Full Text
View/download PDF

4. Age-related differences in employment, insurance, and financial hardship among colorectal cancer patients: a report from the ColoCare Study

Author

Berghuijs, Karely M. van Thiel, Kaddas, Heydon K., Trujillo, Gillian, Rouhani, Gazelle, Chevrier, Amy, Ose, Jennifer, Shibata, David, Toriola, Adetunji T., Figueiredo, Jane C., Peoples, Anita R., Li, Christopher I., Hardikar, Sheetal, Siegel, Erin M., Gigic, Biljana, Schneider, Martin, Ulrich, Cornelia M., and Kirchhoff, Anne C.

Published
2024
Full Text
View/download PDF

5. Genome-wide association analyses of breast cancer in women of African ancestry identify new susceptibility loci and improve risk prediction

Author

Jia, Guochong, Ping, Jie, Guo, Xingyi, Yang, Yaohua, Tao, Ran, Li, Bingshan, Ambs, Stefan, Barnard, Mollie E., Chen, Yu, Garcia-Closas, Montserrat, Gu, Jian, Hu, Jennifer J., Huo, Dezheng, John, Esther M., Li, Christopher I., Li, James L., Nathanson, Katherine L., Nemesure, Barbara, Olopade, Olufunmilayo I., Pal, Tuya, Press, Michael F., Sanderson, Maureen, Sandler, Dale P., Shu, Xiao-Ou, Troester, Melissa A., Yao, Song, Adejumo, Prisca O., Ahearn, Thomas, Brewster, Abenaa M., Hennis, Anselm J. M., Makumbi, Timothy, Ndom, Paul, O’Brien, Katie M., Olshan, Andrew F., Oluwasanu, Mojisola M., Reid, Sonya, Butler, Ebonee N., Huang, Maosheng, Ntekim, Atara, Qian, Huijun, Zhang, Haoyu, Ambrosone, Christine B., Cai, Qiuyin, Long, Jirong, Palmer, Julie R., Haiman, Christopher A., and Zheng, Wei

Published
2024
Full Text
View/download PDF

6. Allometric versus traditional body-shape indices and risk of colorectal cancer: a Mendelian randomization analysis

Author

Rontogianni, Marina O., Bouras, Emmanouil, Aglago, Elom Kouassivi, Freisling, Heinz, Murphy, Neil, Cotterchio, Michelle, Hampe, Jochen, Lindblom, Annika, Pai, Rish K., Pharoah, Paul D. P., Phipps, Amanda I., van Duijnhoven, Franzel J. B., Visvanathan, Kala, van Guelpen, Bethany, Li, Christopher I., Brenner, Hermann, Pellatt, Andrew J., Ogino, Shuji, Gunter, Marc J., Peters, Ulrike, Christakoudi, Sofia, and Tsilidis, Konstantinos K.

Published
2024
Full Text
View/download PDF

7. Using genome and transcriptome data from African-ancestry female participants to identify putative breast cancer susceptibility genes

Author

Ping, Jie, Jia, Guochong, Cai, Qiuyin, Guo, Xingyi, Tao, Ran, Ambrosone, Christine, Huo, Dezheng, Ambs, Stefan, Barnard, Mollie E., Chen, Yu, Garcia-Closas, Montserrat, Gu, Jian, Hu, Jennifer J., John, Esther M., Li, Christopher I., Nathanson, Katherine, Nemesure, Barbara, Olopade, Olufunmilayo I., Pal, Tuya, Press, Michael F., Sanderson, Maureen, Sandler, Dale P., Yoshimatsu, Toshio, Adejumo, Prisca O., Ahearn, Thomas, Brewster, Abenaa M., Hennis, Anselm J. M., Makumbi, Timothy, Ndom, Paul, O’Brien, Katie M., Olshan, Andrew F., Oluwasanu, Mojisola M., Reid, Sonya, Yao, Song, Butler, Ebonee N., Huang, Maosheng, Ntekim, Atara, Li, Bingshan, Troester, Melissa A., Palmer, Julie R., Haiman, Christopher A., Long, Jirong, and Zheng, Wei

Published
2024
Full Text
View/download PDF

8. Fine-mapping analysis including over 254,000 East Asian and European descendants identifies 136 putative colorectal cancer susceptibility genes

Author

Chen, Zhishan, Guo, Xingyi, Tao, Ran, Huyghe, Jeroen R., Law, Philip J., Fernandez-Rozadilla, Ceres, Ping, Jie, Jia, Guochong, Long, Jirong, Li, Chao, Shen, Quanhu, Xie, Yuhan, Timofeeva, Maria N., Thomas, Minta, Schmit, Stephanie L., Díez-Obrero, Virginia, Devall, Matthew, Moratalla-Navarro, Ferran, Fernandez-Tajes, Juan, Palles, Claire, Sherwood, Kitty, Briggs, Sarah E. W., Svinti, Victoria, Donnelly, Kevin, Farrington, Susan M., Blackmur, James, Vaughan-Shaw, Peter G., Shu, Xiao-Ou, Lu, Yingchang, Broderick, Peter, Studd, James, Harrison, Tabitha A., Conti, David V., Schumacher, Fredrick R., Melas, Marilena, Rennert, Gad, Obón-Santacana, Mireia, Martín-Sánchez, Vicente, Oh, Jae Hwan, Kim, Jeongseon, Jee, Sun Ha, Jung, Keum Ji, Kweon, Sun-Seog, Shin, Min-Ho, Shin, Aesun, Ahn, Yoon-Ok, Kim, Dong-Hyun, Oze, Isao, Wen, Wanqing, Matsuo, Keitaro, Matsuda, Koichi, Tanikawa, Chizu, Ren, Zefang, Gao, Yu-Tang, Jia, Wei-Hua, Hopper, John L., Jenkins, Mark A., Win, Aung Ko, Pai, Rish K., Figueiredo, Jane C., Haile, Robert W., Gallinger, Steven, Woods, Michael O., Newcomb, Polly A., Duggan, David, Cheadle, Jeremy P., Kaplan, Richard, Kerr, Rachel, Kerr, David, Kirac, Iva, Böhm, Jan, Mecklin, Jukka-Pekka, Jousilahti, Pekka, Knekt, Paul, Aaltonen, Lauri A., Rissanen, Harri, Pukkala, Eero, Eriksson, Johan G., Cajuso, Tatiana, Hänninen, Ulrika, Kondelin, Johanna, Palin, Kimmo, Tanskanen, Tomas, Renkonen-Sinisalo, Laura, Männistö, Satu, Albanes, Demetrius, Weinstein, Stephanie J., Ruiz-Narvaez, Edward, Palmer, Julie R., Buchanan, Daniel D., Platz, Elizabeth A., Visvanathan, Kala, Ulrich, Cornelia M., Siegel, Erin, Brezina, Stefanie, Gsur, Andrea, Campbell, Peter T., Chang-Claude, Jenny, Hoffmeister, Michael, Brenner, Hermann, Slattery, Martha L., Potter, John D., Tsilidis, Kostas K., Schulze, Matthias B., Gunter, Marc J., Murphy, Neil, Castells, Antoni, Castellví-Bel, Sergi, Moreira, Leticia, Arndt, Volker, Shcherbina, Anna, Bishop, D. Timothy, Giles, Graham G., Southey, Melissa C., Idos, Gregory E., McDonnell, Kevin J., Abu-Ful, Zomoroda, Greenson, Joel K., Shulman, Katerina, Lejbkowicz, Flavio, Offit, Kenneth, Su, Yu-Ru, Steinfelder, Robert, Keku, Temitope O., van Guelpen, Bethany, Hudson, Thomas J., Hampel, Heather, Pearlman, Rachel, Berndt, Sonja I., Hayes, Richard B., Martinez, Marie Elena, Thomas, Sushma S., Pharoah, Paul D. P., Larsson, Susanna C., Yen, Yun, Lenz, Heinz-Josef, White, Emily, Li, Li, Doheny, Kimberly F., Pugh, Elizabeth, Shelford, Tameka, Chan, Andrew T., Cruz-Correa, Marcia, Lindblom, Annika, Hunter, David J., Joshi, Amit D., Schafmayer, Clemens, Scacheri, Peter C., Kundaje, Anshul, Schoen, Robert E., Hampe, Jochen, Stadler, Zsofia K., Vodicka, Pavel, Vodickova, Ludmila, Vymetalkova, Veronika, Edlund, Christopher K., Gauderman, W. James, Shibata, David, Toland, Amanda, Markowitz, Sanford, Kim, Andre, Chanock, Stephen J., van Duijnhoven, Franzel, Feskens, Edith J. M., Sakoda, Lori C., Gago-Dominguez, Manuela, Wolk, Alicja, Pardini, Barbara, FitzGerald, Liesel M., Lee, Soo Chin, Ogino, Shuji, Bien, Stephanie A., Kooperberg, Charles, Li, Christopher I., Lin, Yi, Prentice, Ross, Qu, Conghui, Bézieau, Stéphane, Yamaji, Taiki, Sawada, Norie, Iwasaki, Motoki, Le Marchand, Loic, Wu, Anna H., Qu, Chenxu, McNeil, Caroline E., Coetzee, Gerhard, Hayward, Caroline, Deary, Ian J., Harris, Sarah E., Theodoratou, Evropi, Reid, Stuart, Walker, Marion, Ooi, Li Yin, Lau, Ken S., Zhao, Hongyu, Hsu, Li, Cai, Qiuyin, Dunlop, Malcolm G., Gruber, Stephen B., Houlston, Richard S., Moreno, Victor, Casey, Graham, Peters, Ulrike, Tomlinson, Ian, and Zheng, Wei

Published
2024
Full Text
View/download PDF

9. Functional quality of life among newly diagnosed young adult colorectal cancer survivors compared to older adults: results from the ColoCare Study

Author

Oswald, Laura B., Bloomer, Amanda, Li, Xiaoyin, Jean-Baptiste, Esther, Trujillo, Gillian, Felder, Seth, Small, Brent J., Ose, Jennifer, Hardikar, Sheetal, Strehli, Ildiko, Huang, Lyen C., Mooney, Kathi, Mutch, Matthew G., Chao, Dante, Cohen, Stacey A., Karchi, Meghana, Wood, Elizabeth H., Damerell, Victoria, Loroña, Nicole C., Gong, Jun, Toriola, Adetunji T., Li, Christopher I., Shibata, David, Schneider, Martin, Gigic, Biljana, Figueiredo, Jane C., Jim, Heather S. L., Ulrich, Cornelia M., and Siegel, Erin M.

Published
2024
Full Text
View/download PDF

11. Prospective and Mendelian randomization analyses on the association of circulating fatty acid binding protein 4 (FABP-4) and risk of colorectal cancer

Author

Nimptsch, Katharina, Aleksandrova, Krasimira, Pham, Thu Thi, Papadimitriou, Nikos, Janke, Jürgen, Christakoudi, Sofia, Heath, Alicia, Olsen, Anja, Tjønneland, Anne, Schulze, Matthias B., Katzke, Verena, Kaaks, Rudolf, van Guelpen, Bethany, Harbs, Justin, Palli, Domenico, Macciotta, Alessandra, Pasanisi, Fabrizio, Yohar, Sandra Milena Colorado, Guevara, Marcela, Amiano, Pilar, Grioni, Sara, Jakszyn, Paula Gabriela, Figueiredo, Jane C., Samadder, N. Jewel, Li, Christopher I., Moreno, Victor, Potter, John D., Schoen, Robert E., Um, Caroline Y., Weiderpass, Elisabete, Jenab, Mazda, Gunter, Marc J., and Pischon, Tobias

Published
2023
Full Text
View/download PDF

12. Combining Asian and European genome-wide association studies of colorectal cancer improves risk prediction across racial and ethnic populations

Author

Thomas, Minta, Su, Yu-Ru, Rosenthal, Elisabeth A., Sakoda, Lori C., Schmit, Stephanie L., Timofeeva, Maria N., Chen, Zhishan, Fernandez-Rozadilla, Ceres, Law, Philip J., Murphy, Neil, Carreras-Torres, Robert, Diez-Obrero, Virginia, van Duijnhoven, Franzel J. B., Jiang, Shangqing, Shin, Aesun, Wolk, Alicja, Phipps, Amanda I., Burnett-Hartman, Andrea, Gsur, Andrea, Chan, Andrew T., Zauber, Ann G., Wu, Anna H., Lindblom, Annika, Um, Caroline Y., Tangen, Catherine M., Gignoux, Chris, Newton, Christina, Haiman, Christopher A., Qu, Conghui, Bishop, D. Timothy, Buchanan, Daniel D., Crosslin, David R., Conti, David V., Kim, Dong-Hyun, Hauser, Elizabeth, White, Emily, Siegel, Erin, Schumacher, Fredrick R., Rennert, Gad, Giles, Graham G., Hampel, Heather, Brenner, Hermann, Oze, Isao, Oh, Jae Hwan, Lee, Jeffrey K., Schneider, Jennifer L., Chang-Claude, Jenny, Kim, Jeongseon, Huyghe, Jeroen R., Zheng, Jiayin, Hampe, Jochen, Greenson, Joel, Hopper, John L., Palmer, Julie R., Visvanathan, Kala, Matsuo, Keitaro, Matsuda, Koichi, Jung, Keum Ji, Li, Li, Le Marchand, Loic, Vodickova, Ludmila, Bujanda, Luis, Gunter, Marc J., Matejcic, Marco, Jenkins, Mark A., Slattery, Martha L., D’Amato, Mauro, Wang, Meilin, Hoffmeister, Michael, Woods, Michael O., Kim, Michelle, Song, Mingyang, Iwasaki, Motoki, Du, Mulong, Udaltsova, Natalia, Sawada, Norie, Vodicka, Pavel, Campbell, Peter T., Newcomb, Polly A., Cai, Qiuyin, Pearlman, Rachel, Pai, Rish K., Schoen, Robert E., Steinfelder, Robert S., Haile, Robert W., Vandenputtelaar, Rosita, Prentice, Ross L., Küry, Sébastien, Castellví-Bel, Sergi, Tsugane, Shoichiro, Berndt, Sonja I., Lee, Soo Chin, Brezina, Stefanie, Weinstein, Stephanie J., Chanock, Stephen J., Jee, Sun Ha, Kweon, Sun-Seog, Vadaparampil, Susan, Harrison, Tabitha A., Yamaji, Taiki, Keku, Temitope O., Vymetalkova, Veronika, Arndt, Volker, Jia, Wei-Hua, Shu, Xiao-Ou, Lin, Yi, Ahn, Yoon-Ok, Stadler, Zsofia K., Van Guelpen, Bethany, Ulrich, Cornelia M., Platz, Elizabeth A., Potter, John D., Li, Christopher I., Meester, Reinier, Moreno, Victor, Figueiredo, Jane C., Casey, Graham, Lansdorp Vogelaar, Iris, Dunlop, Malcolm G., Gruber, Stephen B., Hayes, Richard B., Pharoah, Paul D. P., Houlston, Richard S., Jarvik, Gail P., Tomlinson, Ian P., Zheng, Wei, Corley, Douglas A., Peters, Ulrike, and Hsu, Li

Published
2023
Full Text
View/download PDF

13. Associations of combined physical activity and body mass index groups with colorectal cancer survival outcomes

Author

Himbert, Caroline, Ose, Jennifer, Gigic, Biljana, Viskochil, Richard, Santuci, Kelly, Lin, Tengda, Ashworth, Anjelica, Cohan, Jessica N., Scaife, Courtney L., Jedrzkiewicz, Jolanta, Damerell, Victoria, Atkins, Katelyn M., Gong, Jun, Mutch, Matthew G., Bernadt, Corey, Felder, Seth, Sanchez, Julian, Cohen, Stacey A., Krane, Mukta K., Hinkle, Nathan, Wood, Elizabeth, Peoples, Anita R., Figueiredo, Jane C., Toriola, Adetunji T., Siegel, Erin M., Li, Christopher I., Shibata, David, Boucher, Kenneth, Round, June L., Ulrich, Alexis B., Schneider, Martin, Huang, Lyen C., Hardikar, Sheetal, and Ulrich, Cornelia M.

Published
2023
Full Text
View/download PDF

14. Clinical Characteristics and Outcomes of Colorectal Cancer in the ColoCare Study: Differences by Age of Onset

Author

Himbert, Caroline, Figueiredo, Jane C, Shibata, David, Ose, Jennifer, Lin, Tengda, Huang, Lyen C, Peoples, Anita R, Scaife, Courtney L, Pickron, Bartley, Lambert, Laura, Cohan, Jessica N, Bronner, Mary, Felder, Seth, Sanchez, Julian, Dessureault, Sophie, Coppola, Domenico, Hoffman, David M, Nasseri, Yosef F, Decker, Robert W, Zaghiyan, Karen, Murrell, Zuri A, Hendifar, Andrew, Gong, Jun, Firoozmand, Eiman, Gangi, Alexandra, Moore, Beth A, Cologne, Kyle G, El-Masry, Maryliza S, Hinkle, Nathan, Monroe, Justin, Mutch, Matthew, Bernadt, Cory, Chatterjee, Deyali, Sinanan, Mika, Cohen, Stacey A, Wallin, Ulrike, Grady, William M, Lampe, Paul D, Reddi, Deepti, Krane, Mukta, Fichera, Alessandro, Moonka, Ravi, Herpel, Esther, Schirmacher, Peter, Kloor, Matthias, von Knebel-Doeberitz, Magnus, Nattenmueller, Johanna, Kauczor, Hans-Ulrich, Swanson, Eric, Jedrzkiewicz, Jolanta, Schmit, Stephanie L, Gigic, Biljana, Ulrich, Alexis B, Toriola, Adetunji T, Siegel, Erin M, Li, Christopher I, Ulrich, Cornelia M, and Hardikar, Sheetal

Subjects
Biomedical and Clinical Sciences, Oncology and Carcinogenesis, Cancer, Digestive Diseases, Colo-Rectal Cancer, Clinical Research, cohort, colorectal cancer, early onset, epidemiology, Oncology and carcinogenesis
Abstract

Early-onset colorectal cancer has been on the rise in Western populations. Here, we compare patient characteristics between those with early- (

Published
2021

15. Genetically predicted circulating concentrations of micronutrients and risk of colorectal cancer among individuals of European descent: a Mendelian randomization study

Author

Tsilidis, Konstantinos K, Papadimitriou, Nikos, Dimou, Niki, Gill, Dipender, Lewis, Sarah J, Martin, Richard M, Murphy, Neil, Markozannes, Georgios, Zuber, Verena, Cross, Amanda J, Burrows, Kimberley, Lopez, David S, Key, Timothy J, Travis, Ruth C, Perez-Cornago, Aurora, Hunter, David J, van Duijnhoven, Fränzel JB, Albanes, Demetrius, Arndt, Volker, Berndt, Sonja I, Bézieau, Stéphane, Bishop, D Timothy, Boehm, Juergen, Brenner, Hermann, Burnett-Hartman, Andrea, Campbell, Peter T, Casey, Graham, Castellví-Bel, Sergi, Chan, Andrew T, Chang-Claude, Jenny, de la Chapelle, Albert, Figueiredo, Jane C, Gallinger, Steven J, Giles, Graham G, Goodman, Phyllis J, Gsur, Andrea, Hampe, Jochen, Hampel, Heather, Hoffmeister, Michael, Jenkins, Mark A, Keku, Temitope O, Kweon, Sun-Seog, Larsson, Susanna C, Le Marchand, Loic, Li, Christopher I, Li, Li, Lindblom, Annika, Martín, Vicente, Milne, Roger L, Moreno, Victor, Nan, Hongmei, Nassir, Rami, Newcomb, Polly A, Offit, Kenneth, Pharoah, Paul DP, Platz, Elizabeth A, Potter, John D, Qi, Lihong, Rennert, Gad, Sakoda, Lori C, Schafmayer, Clemens, Slattery, Martha L, Snetselaar, Linda, Schenk, Jeanette, Thibodeau, Stephen N, Ulrich, Cornelia M, Van Guelpen, Bethany, Harlid, Sophia, Visvanathan, Kala, Vodickova, Ludmila, Wang, Hansong, White, Emily, Wolk, Alicja, Woods, Michael O, Wu, Anna H, Zheng, Wei, Bueno-de-Mesquita, Bas, Boutron-Ruault, Marie-Christine, Hughes, David J, Jakszyn, Paula, Kühn, Tilman, Palli, Domenico, Riboli, Elio, Giovannucci, Edward L, Banbury, Barbara L, Gruber, Stephen B, Peters, Ulrike, Gunter, Marc J, and on behalf of GECCO, CORECT

Subjects
Complementary and Integrative Health, Digestive Diseases, Clinical Research, Clinical Trials and Supportive Activities, Cancer, Colo-Rectal Cancer, Prevention, Nutrition, Prevention of disease and conditions, and promotion of well-being, 3.3 Nutrition and chemoprevention, Case-Control Studies, Colorectal Neoplasms, Dietary Supplements, Genetic Predisposition to Disease, Humans, Mendelian Randomization Analysis, Micronutrients, Risk Factors, Selenium, Vitamin B 12, White People, Mendelian randomization, genes, nutrition, supplements, colorectal cancer, Engineering, Medical and Health Sciences, Nutrition & Dietetics
Abstract

BackgroundThe literature on associations of circulating concentrations of minerals and vitamins with risk of colorectal cancer is limited and inconsistent. Evidence from randomized controlled trials (RCTs) to support the efficacy of dietary modification or nutrient supplementation for colorectal cancer prevention is also limited.ObjectivesTo complement observational and RCT findings, we investigated associations of genetically predicted concentrations of 11 micronutrients (β-carotene, calcium, copper, folate, iron, magnesium, phosphorus, selenium, vitamin B-6, vitamin B-12, and zinc) with colorectal cancer risk using Mendelian randomization (MR).MethodsTwo-sample MR was conducted using 58,221 individuals with colorectal cancer and 67,694 controls from the Genetics and Epidemiology of Colorectal Cancer Consortium, Colorectal Cancer Transdisciplinary Study, and Colon Cancer Family Registry. Inverse variance-weighted MR analyses were performed with sensitivity analyses to assess the impact of potential violations of MR assumptions.ResultsNominally significant associations were noted for genetically predicted iron concentration and higher risk of colon cancer [ORs per SD (ORSD): 1.08; 95% CI: 1.00, 1.17; P value = 0.05] and similarly for proximal colon cancer, and for vitamin B-12 concentration and higher risk of colorectal cancer (ORSD: 1.12; 95% CI: 1.03, 1.21; P value = 0.01) and similarly for colon cancer. A nominally significant association was also noted for genetically predicted selenium concentration and lower risk of colon cancer (ORSD: 0.98; 95% CI: 0.96, 1.00; P value = 0.05) and similarly for distal colon cancer. These associations were robust to sensitivity analyses. Nominally significant inverse associations were observed for zinc and risk of colorectal and distal colon cancers, but sensitivity analyses could not be performed. None of these findings survived correction for multiple testing. Genetically predicted concentrations of β-carotene, calcium, copper, folate, magnesium, phosphorus, and vitamin B-6 were not associated with disease risk.ConclusionsThese results suggest possible causal associations of circulating iron and vitamin B-12 (positively) and selenium (inversely) with risk of colon cancer.

Published
2021

16. Elucidating the Risk of Colorectal Cancer for Variants in Hereditary Colorectal Cancer Genes

Author

Wang, Xiaoliang, Huyghe, Jeroen R., Joo, Jihoon E., Georgeson, Peter, Arndt, Volker, Berndt, Sonja I., Bézieau, Stéphane, Bien, Stephanie A., Bishop, D. Timothy, Brenner, Hermann, Brezina, Stefanie, Burnett-Hartman, Andrea, Campbell, Peter T., Casey, Graham, Castellví-Bel, Sergi, Chan, Andrew T., Chang-Claude, Jenny, Chen, Xuechen, Conti, David V., Cremolini, Chiara, Diergaarde, Brenda, Figueiredo, Jane C., FitzGerald, Liesel M., Gago-Dominguez, Manuela, Gallinger, Steven, Giles, Graham G., Gsu, Andrea, Gunter, Marc J., Hampe, Jochen, Hampel, Heather, Harrison, Tabitha A., Hoffmeister, Michael, Keku, Temitope O., Kundaje, Anshul, Le Marchand, Loic, Lenz, Heinz-Josef, Li, Christopher I., Li, Li, Lin, Yi, Lindblom, Annika, Moreno, Victor, Murphy, Neil, Newcomb, Polly A., Newton, Christina C., Obón-Santacana, Mireia, Ogino, Shuji, Pai, Rish K., Palmer, Julie R., Pearlman, Rachel, Pharoah, Paul D.P., Phipps, Amanda I., Platz, Elizabeth A., Potter, John D., Rennert, Gad, Sakoda, Lori C., Schafmayer, Clemens, Schmit, Stephanie L., Schoen, Robert E., Slattery, Martha L., Stadler, Zsofia K., Steinfelder, Robert S., Thibodeau, Stephen N., Ulrich, Cornelia M., Um, Caroline Y., van Duijnhoven, Franzel J.B., Van Guelpen, Bethany, Visvanathan, Kala, Vodicka, Pavel, Vodickova, Ludmila, Vymetalkova, Veronika, Weinstein, Stephanie J., White, Emily, Winship, Ingrid M., Wolk, Alicja, Gruber, Stephen B., Jenkins, Mark A., Mahmood, Khalid, Thomas, Minta, Qu, Conghui, Hsu, Li, Buchanan, Daniel D., and Peters, Ulrike

Published
2023
Full Text
View/download PDF

18. An Evaluation of the Utility of Big Data to Supplement Cancer Treatment Information: Linkage Between IQVIA Pharmacy Database and the Surveillance, Epidemiology, and End Results Program.

Author

Tran, Quyen, Warren, Joan L, Barrett, Michael J, Annett, Dave, Marth, Melissa, Cress, Rosemary D, Deapen, Dennis, Glaser, Sally L, Gomez, Scarlett L, Schwartz, Stephen M, Li, Christopher I, Wu, Xiao-Cheng, Enewold, Lindsey, Harlan, Linda C, Rivera, Donna R, Winn, Deborah M, Penberthy, Lynne, and Cronin, Kathleen A

Subjects
Health Services, Breast Cancer, Hematology, Rare Diseases, Cancer, Clinical Research, Good Health and Well Being, Aged, Big Data, Female, Humans, Male, Medicare, Middle Aged, Neoplasms, Pharmacy, SEER Program, United States, Oncology and Carcinogenesis, Oncology & Carcinogenesis
Abstract

Oral anticancer medications (OAMs) are increasingly utilized. We evaluated the representativeness and completeness of IQVIA, a large aggregator of pharmacy data, for breast cancer, colon cancer, chronic myeloid leukemia, and myeloma cases diagnosed in six Surveillance, Epidemiology, and End Results Program (SEER) registries between 2007 and 2011. Patient's SEER and SEER-Medicare data were linked and compared with IQVIA pharmacy data from 2006 to 2012 for specific OAMs. Overall, 67.6% of SEER cases had a pharmacy claim in IQVIA during the treatment assessment window. This varied by location, race and ethnicity, and insurance status. IQVIA consistently identified fewer cases who received an OAM of interest than SEER-Medicare. The difference was least pronounced for breast cancer agents and most pronounced for myeloma agents. The IQVIA pharmacy database included a large portion of persons in the SEER areas. Future studies should assess receipt of OAMs for other cancer sites and in different SEER registries.

Published
2020

19. Factors associated with changes in exercise behaviors during the COVID-19 pandemic

Author

Himbert, Caroline, Hathaway, Cassandra A., Daniels, Bailee, Salas, Karen, Ashworth, Anjelica, Gigic, Biljana, Lin, Tengda, Viskochil, Richard, Kirchhoff, Anne C., Grossman, Douglas, Ose, Jennifer, Tward, Jonathan, Scaife, Courtney, Figueiredo, Jane C., Toriola, Adetunji T., Beck, Anna, Shibata, David, Gonzalez, Brian D., Matsen, Cindy, Christenson, Cristina, Ma, Debra S., Colman, Howard, Hunt, Jason P., Jones, Kevin B., Lee, Catherine J., Larson, Mikaela, Onega, Tracy, Akerley, Wallace L., Li, Christopher I., Schneider, Martin, Penedo, Frank J., Siegel, Erin M., Tworoger, Shelley S., Ulrich, Cornelia M., and Peoples, Anita R.

Published
2022
Full Text
View/download PDF

20. Case-Case Genome-Wide Analyses Identify Subtype-Informative Variants that Confer Risk for Breast Cancer

Author

Sun, Xiaohui, primary, Verma, Shiv Prakash, additional, Jia, Guochong, additional, Wang, Xinjun, additional, Ping, Jie, additional, Guo, Xingyi, additional, Shu, Xiao-Ou, additional, Chen, Jianhong, additional, Derkach, Andriy, additional, Cai, Qiuyin, additional, Liang, Xiaolin, additional, Long, Jirong, additional, Offit, Kenneth, additional, Oh, Jung Hun, additional, Reiner, Anne S., additional, Watt, Gordon P., additional, Woods, Meghan, additional, Yang, Yaohua, additional, Ambrosone, Christine B., additional, Ambs, Stefan, additional, Chen, Yu, additional, Concannon, Patrick, additional, Garcia-Closas, Montserrat, additional, Gu, Jian, additional, Haiman, Christopher A., additional, Hu, Jennifer J., additional, Huo, Dezheng, additional, John, Esther M., additional, Knight, Julia A., additional, Li, Christopher I., additional, Lynch, Charles F., additional, Mellemkjaer, Lene, additional, Nathanson, Katherine L., additional, Nemesure, Barbara, additional, Olopade, Olufunmilayo I., additional, Olshan, Andrew F., additional, Pal, Tuya, additional, Palmer, Julie R., additional, Press, Michael F., additional, Sanderson, Maureen, additional, Sandler, Dale P., additional, Troester, Melissa A., additional, Zheng, Wei, additional, Bernstein, Jonine L., additional, Buas, Matthew F., additional, and Shu, Xiang, additional

Published
2024
Full Text
View/download PDF

21. Metabolic disorders in patients diagnosed with colorectal cancer.

Author

Levy, Julia A., primary, Lorona, Nicole C., additional, Gigic, Biljana, additional, Li, Christopher I., additional, Ose, Jennifer, additional, Shibata, David, additional, Siegel, Erin M., additional, Toriola, Adetunji T., additional, Ulrich, Cornelia M, additional, Hardikar, Sheetal, additional, and Figueiredo, Jane C., additional

Published
2024
Full Text
View/download PDF

22. Identification of potential mediators of the relationship between body mass index and colorectal cancer: a Mendelian randomization analysis

Author

Bouras, Emmanouil, primary, Gill, Dipender, additional, Zuber, Verena, additional, Murphy, Neil, additional, Dimou, Niki, additional, Aleksandrova, Krasimira, additional, Lewis, Sarah J, additional, Martin, Richard M, additional, Yarmolinsky, James, additional, Albanes, Demetrius, additional, Brenner, Hermann, additional, Castellví-Bel, Sergi, additional, Chan, Andrew T, additional, Cheng, Iona, additional, Gruber, Stephen, additional, Van Guelpen, Bethany, additional, Li, Christopher I, additional, Le Marchand, Loic, additional, Newcomb, Polly A, additional, Ogino, Shuji, additional, Pellatt, Andrew, additional, Schmit, Stephanie L, additional, Wolk, Alicja, additional, Wu, Anna H, additional, Peters, Ulrike, additional, Gunter, Marc J, additional, and Tsilidis, Konstantinos K, additional

Published
2024
Full Text
View/download PDF

23. Sex hormones and risk of lung and colorectal cancers in women: a Mendelian randomization study

Author

Denos, Marion, primary, Sun, Yi-Qian, additional, Brumpton, Ben, additional, Li, Yafang, additional, Albanes, Demetrius, additional, Burnett-Hartman, Andrea, additional, Campbell, Peter T, additional, Küry, Sébastien, additional, Li, Christopher I, additional, White, Emily, additional, Samadder, Jewel N, additional, Jenkins, Mark, additional, and Mai, Xiao-Mei, additional

Published
2024
Full Text
View/download PDF

26. Association of circulating leukocyte telomere length with survival in patients with colorectal cancer

Author

Pauleck, Svenja, Gigic, Biljana, Cawthon, Richard M., Ose, Jennifer, Peoples, Anita R., Warby, Christy A., Sinnott, Jennifer A., Lin, Tengda, Boehm, Juergen, Schrotz-King, Petra, Li, Christopher I., Shibata, David, Siegel, Erin M., Figueiredo, Jane C., Toriola, Adetunji T., Schneider, Martin, Ulrich, Alexis B., Hoffmeister, Albrecht, Ulrich, Cornelia M., and Hardikar, Sheetal

Published
2022
Full Text
View/download PDF

28. Statin use and risks of breast cancer recurrence and mortality.

Author

Guo, Hanbing, Malone, Kathleen E., Heckbert, Susan R., and Li, Christopher I.

Subjects
EPIDERMAL growth factor receptors, MEDICARE Part D, PROPORTIONAL hazards models, STATINS (Cardiovascular agents), BREAST cancer, HORMONE receptor positive breast cancer, CANCER relapse
Abstract

Background: Preclinical evidence suggests improved breast cancer survival associated with statin use, but findings from observational studies are conflicting and remain inconclusive. The objective of this study was to assess the association between statin use after cancer diagnosis and cancer outcomes among breast cancer patients. Methods: In this retrospective cohort study, 38,858 women aged ≥66 years who were diagnosed with localized and regional stage breast cancer from 2008 through 2017 were identified from the linked Surveillance, Epidemiology, and End Results Medicare database. Statin use was ascertained from Medicare Part D pharmacy claims data. Multivariable Cox proportional hazards models were used to estimate hazard ratios (HRs) and 95% confidence intervals (CIs) for the association between post‐diagnosis statin use and risks of breast cancer recurrence and breast cancer–specific mortality. Results: Over a median follow‐up of 2.9 years for recurrence and 3.7 years for mortality, 1446 women experienced a recurrence, and 2215 died from breast cancer. The mean duration of post‐diagnosis statin use was 2.2 years. Statin use post‐diagnosis was not associated with recurrence risk (HR, 1.05; 95% CI, 0.91–1.21), but was associated with a reduced risk of cancer‐specific mortality (HR, 0.85; 95% CI, 0.75–0.96). The reduction was more pronounced in women with hormone receptor–positive/human epidermal growth factor receptor 2–negative breast cancer (HR, 0.71; 95% CI, 0.57–0.88). Conclusions: These findings suggest that post‐diagnosis statin use is associated with improved cancer‐specific survival in women with breast cancer and should be confirmed in randomized trials of statin therapy in breast cancer patients. Statin use after cancer diagnosis is associated with improved cancer survival in a large cohort of elderly women with breast cancer, highlighting the potential of statins as anticancer agents in improving breast cancer outcomes. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

29. Executing plans to enhance diversity across cancer centers in the United States: opportunities and challenges.

Author

Li, Christopher I, Rogers, Sherise Chantell, Bult, Carol J, Guerra, Carmen E, Talton, Angela, Williams, Lovoria B, and Law, Wendy

Subjects
*CANCER research, *LEADERSHIP, *BEST practices, *DIVERSITY in the workplace, *LABOR supply
Abstract

Background Lack of diversity in the cancer research workforce persists, which the new requirement for all National Cancer Institute (NCI)–designated cancer centers to have a Plan to Enhance Diversity (PED) seeks to address. However, it is not well understood how different cancer centers are approaching the development and execution of these plans. Our objective was to assess how cancer centers are establishing and pursuing their PED. Methods We conducted a cross-sectional survey of members of the Cancer Center Diversity, Equity and Inclusion Network, which includes all NCI-designated cancer centers and several emerging centers. A total of 62 cancer centers (75% of those invited), including 58 NCI-designated cancer centers (81% of those with this designation), participated and completed a questionnaire that assessed PED leadership, major challenges, implementation strategies, and approach to evaluate PED progress. Results The most common PED challenge identified is recruiting diverse faculty (68% of centers), and the most common strategy currently used to address this is reviewing and revising faculty recruitment practices (67%). The most common approach centers are using to measure PED progress is shifts in demographics (68%), and data on the demographics of faculty, leadership, and trainees are available at 79%, 81%, and 75% of centers, respectively. Conclusions Almost all centers have established a PED leadership structure, however, there is considerable variation in the approaches used to realize PED goals and in the resources provided to support PED work. Realizing opportunities to share and implement common best practices and exemplar programs has the potential to elevate the impact of PED efforts nationally. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

35. Comparison of the disease presentation of early- vs. later-onset colorectal cancer within the prospective ColoCare study.

Author

Gottschalk, Zachary, primary, Redman, Mary Weber, additional, Baker, Kelsey K., additional, Ulrich, Cornelia M, additional, Siegel, Erin M., additional, Figueiredo, Jane C., additional, Shibata, David, additional, Toriola, Adetunji T., additional, Gigic, Biljana, additional, Ose, Jennifer, additional, Lin, Tengda, additional, Hardikar, Sheetal, additional, Li, Christopher I., additional, and Cohen, Stacey A., additional

Published
2024
Full Text
View/download PDF

36. Fusobacterium nucleatum and Clinicopathologic Features of Colorectal Cancer: Results From the ColoCare Study

Author

Eisele, Yannick, Mallea, Patrick M., Gigic, Biljana, Stephens, W. Zac, Warby, Christy A., Buhrke, Kate, Lin, Tengda, Boehm, Juergen, Schrotz-King, Petra, Hardikar, Sheetal, Huang, Lyen C., Pickron, T. Bartley, Scaife, Courtney L., Viskochil, Richard, Koelsch, Torsten, Peoples, Anita R., Pletneva, Maria A., Bronner, Mary, Schneider, Martin, Ulrich, Alexis B., Swanson, Eric A., Toriola, Adetunji T., Shibata, David, Li, Christopher I., Siegel, Erin M., Figueiredo, Jane, Janssen, Klaus-Peter, Hauner, Hans, Round, June, Ulrich, Cornelia M., Holowatyj, Andreana N., and Ose, Jennifer

Published
2021
Full Text
View/download PDF

38. Identifying Novel Susceptibility Genes for Colorectal Cancer Risk From a Transcriptome-Wide Association Study of 125,478 Subjects

Author

Guo, Xingyi, Lin, Weiqiang, Wen, Wanqing, Huyghe, Jeroen, Bien, Stephanie, Cai, Qiuyin, Harrison, Tabitha, Chen, Zhishan, Qu, Conghui, Bao, Jiandong, Long, Jirong, Yuan, Yuan, Wang, Fangqin, Bai, Mengqiu, Abecasis, Goncalo R., Albanes, Demetrius, Berndt, Sonja I., Bézieau, Stéphane, Bishop, D. Timothy, Brenner, Hermann, Buch, Stephan, Burnett-Hartman, Andrea, Campbell, Peter T., Castellví-Bel, Sergi, Chan, Andrew T., Chang-Claude, Jenny, Chanock, Stephen J., Cho, Sang Hee, Conti, David V., Chapelle, Albert de la, Feskens, Edith J.M., Gallinger, Steven J., Giles, Graham G., Goodman, Phyllis J., Gsur, Andrea, Guinter, Mark, Gunter, Marc J., Hampe, Jochen, Hampel, Heather, Hayes, Richard B., Hoffmeister, Michael, Kampman, Ellen, Kang, Hyun Min, Keku, Temitope O., Kim, Hyeong Rok, Le Marchand, Loic, Lee, Soo Chin, Li, Christopher I., Li, Li, Lindblom, Annika, Lindor, Noralane, Milne, Roger L., Moreno, Victor, Murphy, Neil, Newcomb, Polly A., Nickerson, Deborah A., Offit, Kenneth, Pearlman, Rachel, Pharoah, Paul D.P., Platz, Elizabeth A., Potter, John D., Rennert, Gad, Sakoda, Lori C., Schafmayer, Clemens, Schmit, Stephanie L., Schoen, Robert E., Schumacher, Fredrick R., Slattery, Martha L., Su, Yu-Ru, Tangen, Catherine M., Ulrich, Cornelia M., van Duijnhoven, Franzel J.B., Van Guelpen, Bethany, Visvanathan, Kala, Vodicka, Pavel, Vodickova, Ludmila, Vymetalkova, Veronika, Wang, Xiaoliang, White, Emily, Wolk, Alicja, Woods, Michael O., Casey, Graham, Hsu, Li, Jenkins, Mark A., Gruber, Stephen B., Peters, Ulrike, and Zheng, Wei

Published
2021
Full Text
View/download PDF

39. Relationships Among Physical Activity, Sleep, and Cancer-related Fatigue: Results From the International ColoCare Study

Author

Crowder, Sylvia L, primary, Li, Xiaoyin, additional, Himbert, Caroline, additional, Viskochil, Richard, additional, Hoogland, Aasha I, additional, Gudenkauf, Lisa M, additional, Oswald, Laura B, additional, Gonzalez, Brian D, additional, Small, Brent J, additional, Ulrich, Cornelia M, additional, Ose, Jennifer, additional, Peoples, Anita R, additional, Li, Christopher I, additional, Shibata, David, additional, Toriola, Adetunji T, additional, Gigic, Biljana, additional, Playdon, Mary C, additional, Hardikar, Sheetal, additional, Bower, Julienne, additional, Siegel, Erin M, additional, Figueiredo, Jane C, additional, and Jim, Heather S L, additional

Published
2023
Full Text
View/download PDF

41. Data gaps and opportunities for modeling cancer health equity

Author

Trentham-Dietz, Amy, primary, Corley, Douglas A, additional, Del Vecchio, Natalie J, additional, Greenlee, Robert T, additional, Haas, Jennifer S, additional, Hubbard, Rebecca A, additional, Hughes, Amy E, additional, Kim, Jane J, additional, Kobrin, Sarah, additional, Li, Christopher I, additional, Meza, Rafael, additional, Neslund-Dudas, Christine M, additional, and Tiro, Jasmin A, additional

Published
2023
Full Text
View/download PDF

44. Identifying post-menopausal women at elevated risk for epithelial ovarian cancer

Author

Urban, Nicole, Hawley, Sarah, Janes, Holly, Karlan, Beth Y, Berg, Christine D, Drescher, Charles W, Manson, JoAnn E, Palomares, Melanie R, Daly, Mary B, Wactawski-Wende, Jean, O'Sullivan, Mary J, Thorpe, Jason, Robinson, Randal D, Lane, Dorothy, Li, Christopher I, and Anderson, Garnet L

Subjects
Rare Diseases, Clinical Research, Aging, Ovarian Cancer, Prevention, Breast Cancer, Estrogen, Cancer, Aged, Aged, 80 and over, Biomarkers, Tumor, Breast Feeding, Breast Neoplasms, CA-125 Antigen, Carcinoma, Ovarian Epithelial, Case-Control Studies, Contraceptives, Oral, Hormonal, Estrogen Replacement Therapy, Female, Humans, Middle Aged, Neoplasms, Glandular and Epithelial, Ovarian Neoplasms, Parity, Postmenopause, Proportional Hazards Models, Proteins, Risk Assessment, Risk Factors, Sterilization, Tubal, Talc, WAP Four-Disulfide Core Domain Protein 2, Ovarian cancer, Risk prediction, CA125, HE4, Oncology and Carcinogenesis, Paediatrics and Reproductive Medicine, Oncology & Carcinogenesis
Abstract

ObjectiveWe developed and validated a hybrid risk classifier combining serum markers and epidemiologic risk factors to identify post-menopausal women at elevated risk for invasive fallopian tube, primary peritoneal, and ovarian epithelial carcinoma.MethodsTo select epidemiologic risk factors for use in the classifier, Cox proportional hazards analyses were conducted using 74,786 Women's Health Initiative (WHI) Observational Study (OS) participants. To construct a combination classifier, 210 WHI OS cases and 536 matched controls with serum marker measurements were analyzed; validation employed 143 cases and 725 matched controls from the WHI Clinical Trial (CT) with similar data.ResultsAnalyses identified a combination risk classifier composed of two elevated-risk groups: 1) women with CA125 or HE4 exceeding a 98% specificity threshold; and 2) women with intact fallopian tubes, prior use of menopausal hormone therapy for at least two years, and either a first degree relative with breast or ovarian cancer or a personal history of breast cancer. In the WHI OS population, it classified 13% of women as elevated risk, identifying 30% of ovarian cancers diagnosed up to 7.8years post-enrollment (Hazard Ratio [HR]=2.6, p

Published
2015

48. Relationships Among Physical Activity, Sleep, and Cancer-related Fatigue: Results From the International ColoCare Study.

Author

Crowder, Sylvia L, Li, Xiaoyin, Himbert, Caroline, Viskochil, Richard, Hoogland, Aasha I, Gudenkauf, Lisa M, Oswald, Laura B, Gonzalez, Brian D, Small, Brent J, Ulrich, Cornelia M, Ose, Jennifer, Peoples, Anita R, Li, Christopher I, Shibata, David, Toriola, Adetunji T, Gigic, Biljana, Playdon, Mary C, Hardikar, Sheetal, Bower, Julienne, and Siegel, Erin M

Subjects
PHYSICAL activity, CANCER fatigue, SLEEP, FATIGUE (Physiology), HEALTH behavior, CANCER patients, POLYSOMNOGRAPHY
Abstract

Background Risk factors for cancer-related fatigue are understudied in colorectal cancer. Purpose This study aimed to address this critical gap in the literature by (a) describing changes in colorectal cancer-related fatigue and health behavior (physical activity, sleep problems) and (b) examining if physical activity and sleep problems predict fatigue trajectories from baseline (approximately at the time of diagnosis), to 6- and 12 months after enrollment. Methods Patients participating in the international ColoCare Study completed self-report measures at baseline (approximately time of diagnosis), 6-, and 12 months assessing physical activity using the International Physical Activity Questionnaire (IPAQ) and fatigue and sleep using the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire (EORTC-QLQ-C30). Mixed-effect models examined changes in physical activity, sleep problems, and fatigue. Cross-lagged panel models examined bidirectional relationships between physical activity or sleep and fatigue across time. Results Colorectal cancer patients (n = 649) had a mean age of 61 ± 13 years. Most were male (59%), non-Hispanic White (91%), diagnosed with Stages III–IV (56%) colon cancer (58%), and treated with surgery (98%). Within-person cross-lagged models indicated higher physical activity at Month 6 was associated with higher fatigue at Month 12 (β = 0.26, p =.016). When stratified by cancer stage (I–II vs. III–IV), the relationship between physical activity at Month 6 and fatigue at Month 12 existed only for patients with advanced cancer (Stages III and IV, β = 0.43, p =.035). Cross-lagged associations for sleep and fatigue from baseline to Month 6 were only observed in patients with Stages III or IV cancer, however, there was a clear cross-sectional association between sleep problems and fatigue at baseline and Month 6. Conclusions Within-person and cross-lagged association models suggest fatiguability may become increasingly problematic for patients with advanced colorectal cancer the first year after diagnosis. In addition, sleep problems were consistently associated with higher fatigue in the first year, regardless of cancer stage. Trial registration The international ColoCare Study was registered on clinicaltrials.gov, NCT02328677, in December 2014. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

49. Alcohol, Smoking, and Risks of Breast Cancer Recurrence and Mortality among Women with Luminal, Triple-Negative, and HER2-Overexpressing Breast Cancer.

Author

Loroña, Nicole C., Othus, Megan, Malone, Kathleen E., Linden, Hannah M., Tang, Mei-Tzu C., and Li, Christopher I.

Abstract

Background: This study evaluates the relationship between smoking, alcohol, and breast cancer outcomes according to molecular subtype. Methods: This population-based prospective cohort consisted of 3,876 women ages 20 to 69 diagnosed with a first primary invasive breast cancer from 2004 to 2015 in the Seattle-Puget Sound region. Breast cancer was categorized into three subtypes based on estrogen receptor (ER), progesterone receptor (PR), and HER2 expressions: luminal (ER+), triple-negative (TN; ER-/PR-/HER2-), and HER2-overexpressing (H2E; ER-/HER2+). We fit Cox proportional hazards models to assess the association between alcohol consumption and smoking status at diagnosis and risks of recurrence, breast cancer-specific mortality, and all-cause mortality. Results: Histories of ever smoking [HR, 1.33; 95% confidence interval (CI), 1.01-1.74] and current smoking (HR, 1.59; 95% CI, 1.07-2.35) were associated with greater risk of breast cancer recurrence among TN cases. Smoking was also associated with greater risk of recurrence to bone among all cases and among luminal cases. Elevated risks of breast cancer-specific and all-cause mortality were observed among current smokers across all subtypes. Alcohol use was not positively associated with risk of recurrence or mortality overall; however, TN patients who drank four or more drinks per week had a decreased risk of recurrence (HR, 0.71; 95% CI, 0.51-0.98) and breast cancer-specific mortality (HR, 0.73; 95% CI, 0.55-0.97) compared with non-current drinkers. Conclusions: Patients with breast cancer with a history of smoking at diagnosis have elevated risks of recurrence and mortality. [ABSTRACT FROM AUTHOR]

Published
2024
Full Text
View/download PDF

50. Trajectories and risk factors of fatigue following colorectal cancer diagnosis

Author

Li, Xiaoyin, primary, Hoogland, Aasha I., additional, Small, Brent J., additional, Crowder, Sylvia L., additional, Gonzalez, Brian D., additional, Oswald, Laura B., additional, Sleight, Alix G., additional, Nguyen, Nathalie, additional, Lorona, Nicole C., additional, Damerell, Victoria, additional, Komrokji, Khaled R., additional, Mooney, Kathi, additional, Playdon, Mary C., additional, Ulrich, Cornelia M., additional, Li, Christopher I., additional, Shibata, David, additional, Toriola, Adetunji T., additional, Ose, Jennifer, additional, Peoples, Anita R., additional, Siegel, Erin M., additional, Bower, Julienne E., additional, Schneider, Martin, additional, Gigic, Biljana, additional, Figueiredo, Jane C., additional, and Jim, Heather S. L., additional

Published
2023
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results